Previous close | 32.66 |
Open | 33.05 |
Bid | 31.85 x 900 |
Ask | 32.98 x 800 |
Day's range | 32.49 - 33.34 |
52-week range | 17.30 - 35.73 |
Volume | |
Avg. volume | 299,500 |
Market cap | 1.566B |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.37 |
Earnings date | 01 Aug 2023 - 07 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 39.25 |
Vericel Corporation (VCEL) delivered earnings and revenue surprises of -23.08% and 6.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Allogene Therapeutics (ALLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Vericel Corporation's ( NASDAQ:VCEL ) price-to-sales (or "P/S") ratio of 8.6x might make it look like a buy right now...
Vericel Corporation (VCEL) delivered earnings and revenue surprises of 500% and 0.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...
Vericel Corporation (VCEL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Vericel ( NASDAQ:VCEL ) Third Quarter 2022 Results Key Financial Results Revenue: US$38.6m (up 12% from 3Q 2021). Net...
Vericel Corporation (VCEL) delivered earnings and revenue surprises of -16.67% and 3.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The average of price targets set by Wall Street analysts indicates a potential upside of 52.8% in Vericel Corporation (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Welcome to Vericel's second quarter 2022 conference call to discuss our financial results and business highlights. Please note that a copy of our financial results press release and a short presentation with highlights in today's call are available on the Investor Relations section of our website. Thank you, Eric, and good morning, everyone.
Vericel Corporation (VCEL) delivered earnings and revenue surprises of -46.15% and 3.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
It hasn't been the best quarter for Vericel Corporation ( NASDAQ:VCEL ) shareholders, since the share price has fallen...